Find activities

55 results

  • Efficient Funding of Chemotherapy (EFC) review

    The Efficient Funding of Chemotherapy (EFC) Program provides funding for chemotherapy medicines used for the treatment of cancer that are administered through infusion or injection at public or private hospitals. Not all chemotherapy medicines are provided through the EFC Program, but may be subsidised through the broader Pharmaceutical Benefits Scheme (PBS). In the 2020-21 Budget, the Government announced a review of the current EFC Program. The review will look at the impact... More
    Closed 2 July 2021
  • Draft National Preventive Health Strategy

    Preventive health is a key pillar of Australia’s Long Term National Health Plan with mental health. In June 2019, the Minister for Health, the Hon Greg Hunt MP announced that the Australian Government would develop a 10-year National Preventive Health Strategy (the Strategy). In April 2020 due to the COVID-19 pandemic, the Minister agreed to delay the public consultation process and extend the timeframe of the Strategy until 2021. An Expert Steering... More
    Closed 19 April 2021
  • Aspirations for the food regulatory system

    Reform of the food regulatory system In March 2020, the Australian New Zealand Ministerial Forum on Food Regulation (the Forum) endorsed an implementation plan for an ambitious reform agenda for the food regulatory system aimed at ensuring the system remains strong, robust and agile into the future. The reform agenda is being progressed through a number of interconnected projects. This consultation is part of the first stage of the Review of the Intergovernmental Food Regulation... More
    Closed 22 January 2021
  • Proposed changes to the recommended use of the rabies vaccine

    The Australian Technical Advisory Group on Immunisation (ATAGI) is consulting with stakeholders on proposed changes to rabies vaccination recommendations for inclusion in the Australian Immunisation Handbook, with an intention to submit the recommendation to the National Health and Medical Research Council (NHMRC) for its approval under section 14A of the National Health and Medical Research Council Act 1992. The draft recommendations and the rationale for the changes are outlined in the... More
    Closed 18 November 2020
  • Consultation on the National Youth Policy Framework

    We know the importance of investing in Australia’s young people, and believe in their power to create positive change. For us to achieve meaningful change now and into the future, we must involve young people in the decisions that affect them. To inform the development of the National Youth Policy Framework, we have created a national survey for young people aged 18 and over. The survey gives young Australians a chance to tell us their views on what is important to them. It... More
    Closed 12 October 2020
  • Medical Research Future Fund consultation to inform the third Australian Medical Research and Innovation Priorities 2020-2022

    Consistent with the Medical Research Future Fund Act 2015 (the Act), the independent Australian Medical Research Advisory Board (AMRAB) is conducting a consultation to develop the Medical Research Future Fund (MRFF) Australian Medical Research and Innovation Priorities 2020-22 (the Priorities) . The 2020-22 Priorities must be tabled in the Australian Parliament by 6 November 2020 . The Priorities are considered by the Minister for Health before... More
    Closed 7 October 2020
  • Consultation Paper for the National Preventive Health Strategy

    Informing the National Preventive Health Strategy Preventive health is a key pillar of Australia’s Long Term National Health Plan. As announced by the Minister for Health, the Hon Greg Hunt MP in June 2019 , the Australian Government is developing a 10-year National Preventive Health Strategy (the Strategy). Due to the emergence of COVID-19, the development of the Strategy was paused. The Strategy will now be developed by March 2021 . A Consultation Paper has been... More
    Closed 28 September 2020
  • National Injury Prevention Strategy

    The National Injury Prevention Strategy 2020-2030 (the Strategy) aims to create a national focus on injuries and their prevention. The Strategy will take a broad approach to injury and aims to address both intentional and unintentional injuries across all ages and population groups. The Strategy is currently being developed and recognises that: Injuries are the leading cause of death of all people aged 1-44 years; Intentional and unintentional injuries are... More
    Closed 3 July 2020
  • Proposed changes to the recommended use of pneumococcal vaccines

    The Australian Technical Advisory Group on Immunisation (ATAGI) is consulting with stakeholders on proposed changes to the pneumococcal vaccination recommendations for inclusion in the Australian Immunisation Handbook, with an intention to submit the recommendation to the National Health and Medical Research Council (NHMRC) for its approval under section 14A of the National Health and Medical Research Council Act 1992. The draft recommendations and the rationale for the changes are... More
    Closed 1 March 2020
  • Establishing a National Action Plan for the Health of Children and Young People: 2020 to 2030

    On 15 August 2018, the Minister for Health, the Hon Greg Hunt MP, announced at the Royal Australasian College of Physicians Forum on Inequities in Child Health in Canberra, the commencement of a process to establish a National Action Plan for the Health of Children and Young People: 2020 to 2030 (the Action Plan). The Action Plan will: build on the Council of Australian Governments' Healthy, Safe and Thriving: National Strategic Framework for Child and Youth Health, ... More
    Closed 28 March 2019
  • Developing the Implementation Plans for the National Blood Borne Viruses and Sexually Transmissible Infections Strategies 2018-2022

    The five National Blood Borne Viruses (BBV) and Sexually Transmissible Infections (STI) Strategies set the direction for Australia’s continuing response to BBV and STI from 2018 to 2022. Together, the strategies outline a framework for a high quality and coordinated national response to BBV and STI in Australia. These five strategies include: • Third National Hepatitis B Strategy • Fifth National Hepatitis C Strategy • Eighth National HIV Strategy ... More
    Closed 22 February 2019
  • Proposed changes to the recommended use of pertussis vaccines in pregnant women

    The Australian Technical Advisory Group on Immunisation (ATAGI) is consulting with stakeholders on proposed changes to the maternal pertussis vaccination recommendations for inclusion in the Australian Immunisation Handbook, with an intention to submit the recommendation to the National Health and Medical Research Council (NHMRC) for its approval under section 14A of the National Health and Medical Research Council Act 1992. The draft recommendations and the rationale for the changes are... More
    Closed 9 February 2019
  • Review of the Quality Use of Medicines Program's Delivery by the National Prescribing Service (NPS MedicineWise)

    The Department of Health (the Department) invites submissions to inform the Review of the Quality Use of Medicines Program's delivery by NPS MedicineWise (the Review). The Review is being conducted by Emeritus Professor Lloyd Sansom AO. Context The Australian Government funds the not-for-profit, NPS MedicineWise, to provide evidence based information, support tools and education services to health professionals and consumers to improve the quality use of medicines and... More
    Closed 24 January 2019
  • Pregnancy Care Guidelines Review

    This consultation is seeking feedback as part of a review of selected topics under the Pregnancy Care Guidelines. The topics included in this consultation are: Cervical length measurement to predict preterm birth Syphilis Chlamydia Cytomegalovirus Prolonged pregnancy Pregnancy Care Guidelines The Pregnancy Care Guidelines are designed to support Australian maternity services to provide high-quality,... More
    Closed 15 November 2018
  • Establishing a National Men's Health Strategy for 2020 to 2030

    Australian males generally enjoy better health and a longer life expectancy than males in most other countries in the world. Yet, on average, Australian males have a shorter life expectancy than Australian females, and some population groups of males, particularly Aboriginal and Torres Strait Islander males, have significantly shorter life expectancy than others. On 13 June 2018, the Minister for Health, the Hon Greg Hunt MP announced the commencement of a process to establish a... More
    Closed 5 November 2018
  • Establishing a National Women's Health Strategy for 2020 to 2030

    On 2 March 2018, Minister Hunt announced at the National Women’s Health Summit in Sydney, the commencement of a process to establish a national women’s health strategy for 2020 to 2030. The Strategy will take into account changes in the policy environment, identification of gaps and emerging issues so that health system resources at the national and jurisdictional levels are directed at efficiently addressing the health issues that affect women and girls. The Strategy will... More
    Closed 5 November 2018
  • Medical Research Future Fund consultation to inform the second Australian Medical Research and Innovation Priorities 2018-2020

    Consistent with the Medical Research Future Fund Act 2015 (the Act), the independent Australian Medical Research Advisory Board (AMRAB) is conducting a national consultation to inform the development of the second set of Medical Research Future Fund (MRFF) Australian Medical Research and Innovation Priorities (Priorities) 2018-2020. The timeframe is chosen to ensure the second set of Priorities takes effect from the day the inaugural MRFF Priorities expire, 8 November 2018. MRFF... More
    Closed 31 August 2018
  • Proposed changes to the meningococcal and Haemophilus influenzae type B disease chapters

    The Australian Technical Advisory Group on Immunisation (ATAGI) is consulting with stakeholders on proposed changes to meningococcal and Haemophilus influenzae type B vaccination recommendations for inclusion in the Australian Immunisation Handbook, with an intention to submit the recommendation to the National Health and Medical Research Council (NHMRC) for its approval under section 14A of the National Health and Medical Research Council Act 1992. The draft recommendations and the... More
    Closed 6 May 2018
  • Health in the 2030 Agenda for Sustainable Development

    Purpose We are seeking information on domestic and international initiatives that align with the 2030 Agenda for Sustainable Development (the 2030 Agenda) and contribute to the health and wellbeing of our population, to inform the health related aspects of Australia’s Voluntary National Review (VNR) in 2018. What information are we looking for? We are interested in case studies or planned initiatives that align with the health-related Sustainable Development Goals (SDGs) and... More
    Closed 19 January 2018
  • Proposed changes to the recommended use of human papillomavirus (HPV) vaccines

    The Australian Technical Advisory Group on Immunisation (ATAGI) is consulting with stakeholders on proposed changes to the HPV vaccination recommendations for inclusion in the Australian Immunisation Handbook, with an intention to submit the recommendation to the National Health and Medical Research Council (NHMRC) for its approval under section 14A of the National Health and Medical Research Council Act 1992. The draft recommendations and the rationale for the changes are outlined in the... More
    Closed 30 November 2017
  • Public submissions to the five year review of the Health Star Rating system

    Introduction The Health Star Rating (HSR) Advisory Committee (HSRAC), responsible for overseeing the implementation, monitoring and evaluation of the HSR system, is undertaking a five year review of the HSR system. The HSR system is a front-of-pack labelling (FoPL) scheme intended to assist consumers in making healthier diet choices. The findings of the review will be provided to the Australia and New Zealand Ministerial Forum on Food Regulation (Forum) in mid‑2019. In parallel... More
    Closed 17 August 2017
  • Pharmacy Review - Submissions to the Interim Report

    Submit your response to the Interim Report The Panel for the Review of Pharmacy Remuneration and Regulation welcomes feedback on the reform options presented in its Interim Report. The issues contained in the Interim Report are complex, with the potential to impact significantly on community pharmacy. For this reason, the Panel invites you to provide any feedback on the proposed options and new information that may warrant consideration as the Panel deliberates on its Final Report.... More
    Closed 23 July 2017
  • Pharmacy Review - Responses to the Interim Report

    The Interim Report presents the findings and options for reform arising from the Review of Pharmacy Remuneration and Regulation. The issues in this report are complex, with the potential to impact significantly on community pharmacy. For this reason, the Review Panel invites you to provide any feedback on the proposed options and new information that may warrant consideration as the Panel develops its Final Report. It is necessary that evidence is provided to support all considerations and... More
    Closed 23 July 2017
  • Medical Research Future Fund consultation for the development of the Australian Medical Research and Innovation Strategy and related Priorities

    This phase of the consultation process is now closed. The Australian Medical Research Advisory Board held its first meeting at Parliament House on 4 May 2016. Under the Medical Research Future Fund Act 2015, the Advisory Board is tasked with determining the Australian Medical Research and Innovation Strategy (Strategy) and related Priorities. The Strategy is determined every five years and the Priorities every two years. Members of the Advisory Board want to work with the community to... More
    Closed 6 June 2016
  • Pharmacy Trial Program

    The Australian Government recognises the important role that the pharmacy profession can play in primary care and in improving patient health outcomes. Primary health care plays an important role in broader population health. Primary health care providers, whether general practitioners, allied health professionals, Aboriginal health workers, nurses, pharmacists or other providers all play an important role in health promotion, prevention of chronic disease, risk assessment and early... More
    Closed 29 April 2016
55 results. Page 2 of 2